Evidence map›Paper›PMID 34189651›Full record

ArticleCancer causes & control : CCC2021

Prostate cancer patients' self-reported participation in research: an examination of racial/ethnic disparities.

Nynikka R Palmer, Hala T Borno, Steven E Gregorich, Jennifer Livaudais-Toman, Celia P Kaplan

Open access · hybridAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nynikka R PalmerDepartment of Medicine, Division of General Internal Medicine at Zuckerberg, San Francisco General Hospital, University of California San Francisco, UCSF, 1001 Potrero Avenue, Box 1364, San Francisco, CA, 94143, USA. nynikka.palmer@ucsf.edu.ORCID https://orcid.org/0000-0002-5311-447X
Hala T BornoHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, USA.
Steven E GregorichDepartment of Medicine, Division of General Internal Medicine, University of California San Francisco, San Francisco, USA.
Jennifer Livaudais-TomanDepartment of Medicine, Division of General Internal Medicine, University of California San Francisco, San Francisco, USA.
Celia P KaplanHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, USA.
University of California, San Francisco · USSan Francisco General Hospital · US

Funding

CALIFORNIA COORDINATED CANCER PREVENTION & CONTROL PROGRAMU58DP003862 · DP · CALIFORNIA STATE DEPT OF PUBLIC HEALTH · PI SNIPES, KURT P · 2012 to 2014
$31.5M
RESOURCE CENTER FOR AGING RESEARCH IN DIVERSE POPULATIONP30AG015272 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Torsten Brian Neilands · 1997 to 2026
$19.5M
Constructing a Relational Bridge to Achieve High-Quality Prostate Cancer Care for African AmericansK01CA211965 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PALMER, NYNIKKA · 2017 to 2022
$1.1M
NCCDPHP CDC HHS U58 DP003862NCI NIH HHS HHSN261201000034CNCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS HHSN261201000140CNCI NIH HHS K01 CA211965NCI NIH HHS K01CA211965NIA NIH HHS 4P30-AG015272-20NIA NIH HHS P30 AG015272
6 · The paper itself

Abstract

purposeWe examined prostate cancer patients' participation in research and associated factors by race/ethnicity in a multiethnic sample.

methodsMen with a new diagnosis of prostate cancer were identified through the California Cancer Registry. Patients completed a cross-sectional telephone interview in English, Spanish, Cantonese or Mandarin. Multivariable logistic regression models, stratified by race/ethnicity, estimated the associations of patient demographic and health characteristics with participation in (1) any research, (2) behavioral research, and (3) biological/clinical research.

resultsWe included 855 prostate cancer patients: African American (19%), Asian American (15%), Latino (24%), and White (42%). In the overall model of participation in any research, African American men (Odds Ratio (OR) = 2.54, 95% CI 1.63-3.94), and those with two or more comorbidities (OR = 2.20, 95% CI 1.27-3.80) were more likely to report participation. Men 65 years old and older (OR = 0.65, 95% CI 0.47-0.91), those who were married or living with a partner (OR = 0.67, 95% CI 0.45-0.98), and those who completed the interview in Spanish (OR = 0.36, 95% CI 0.15-0.85) were less likely to report participating in any research. Stratified analyses identified racial/ethnic-specific sociodemographic characteristics associated with lower research participation, including Spanish or Chinese language, older age, and lower education.

conclusionAfrican American prostate cancer patients reported higher research participation than all other groups. However, recruitment efforts are still needed to overcome barriers to participation for Spanish and Chinese speakers, and barriers among older adults and those with lower education levels.

Indexed as

Patient ParticipationAgedAsianClinical Trials as TopicCross-Sectional StudiesEthnicityHispanic or LatinoHumansMaleProstatic NeoplasmsSelf ReportUnited StatesWhite PeopleHealthcare disparitiesMenMinority groupsProstatic neoplasmResearch subjects

Identifiers

PMID34189651
PMCPMC8416807
OpenAlexW3176659042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.